Literature DB >> 17056191

Predictive factors of tumor control and survival after radiosurgery for local failures of nasopharyngeal carcinoma.

Daniel T T Chua1, Jonathan S T Sham, Kwan-Ngai Hung, Lucullus H T Leung, Gordon K H Au.   

Abstract

BACKGROUND: Stereotactic radiosurgery has been employed as a salvage treatment of local failures of nasopharyngeal carcinoma (NPC). To identify patients that would benefit from radiosurgery, we reviewed our data with emphasis on factors that predicted treatment outcome. PATIENTS AND METHODS: A total of 48 patients with local failures of NPC were treated by stereotactic radiosurgery between March 1996 and February 2005. Radiosurgery was administered using a modified linear accelerator with single or multiple isocenters to deliver a median dose of 12.5 Gy to the target periphery. Median follow-up was 54 months.
RESULTS: Five-year local failure-free probability after radiosurgery was 47.2% and 5-year overall survival rate was 46.9%. Neuroendocrine complications occurred in 27% of patients but there were no treatment-related deaths. Time interval from primary radiotherapy, retreatment T stage, prior local failures and tumor volume were significant predictive factors of local control and/or survival whereas age was of marginal significance in predicting survival. A radiosurgery prognostic scoring system was designed based on these predictive factors. Five-year local failure-free probabilities in patients with good, intermediate and poor prognostic scores were 100%, 42.5%, and 9.6%. The corresponding five-year overall survival rates were 100%, 51.1%, and 0%.
CONCLUSION: Important factors that predicted tumor control and survival after radiosurgery were identified. Patients with good prognostic score should be treated by radiosurgery in view of the excellent results. Patients with intermediate prognostic score may also be treated by radiosurgery but those with poor prognostic score should receive other salvage treatments.

Entities:  

Mesh:

Year:  2006        PMID: 17056191     DOI: 10.1016/j.ijrobp.2006.07.1364

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

Review 1.  Current treatment options for recurrent nasopharyngeal cancer.

Authors:  Carlos Suárez; Juan P Rodrigo; Alessandra Rinaldo; Johannes A Langendijk; Ashok R Shaha; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-24       Impact factor: 2.503

2.  Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.

Authors:  Falk Roeder; Felix Zwicker; Ladan Saleh-Ebrahimi; Carmen Timke; Christian Thieke; Marc Bischof; Juergen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2011-03-01       Impact factor: 3.481

Review 3.  Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy.

Authors:  Hideya Yamazaki; Naohiro Kodani; Mikio Ogita; Kengo Sato; Kengo Himei
Journal:  Radiat Oncol       Date:  2011-08-21       Impact factor: 3.481

4.  Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy.

Authors:  WeiWei Xiao; Shuai Liu; YunMing Tian; Ying Guan; ShaoMin Huang; ChengGuang Lin; Chong Zhao; TaiXiang Lu; Fei Han
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

5.  Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma.

Authors:  Feng Liu; Jian-ping Xiao; Guo-zhen Xu; Li Gao; Ying-jie Xu; Ye Zhang; Xue-song Jiang; Jun-lin Yi; Jing-wei Luo; Xiao-dong Huang; Fu-kui Huan; Hao Fang; Bao Wan; Ye-xiong Li
Journal:  Radiat Oncol       Date:  2013-06-27       Impact factor: 3.481

6.  Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.

Authors:  Y-M Tian; Y-H Tian; L Zeng; S Liu; Y Guan; T-X Lu; F Han
Journal:  Br J Cancer       Date:  2013-12-12       Impact factor: 7.640

7.  Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.

Authors:  T Finazzi; T Rordorf; K Ikenberg; G F Huber; M Guckenberger; H I Garcia Schueler
Journal:  BMC Cancer       Date:  2018-04-06       Impact factor: 4.430

8.  Gamma Knife Radiosurgery Using Co-Registration with PET-CT and MRI for Recurrent Nasopharyngeal Carcinoma with Previous Radiotherapy : A Single Center 14-Year Experience.

Authors:  Chaejin Lee; Seong-Hyun Park; Sang-Youl Yoon; Ki-Su Park; Jeong-Hyun Hwang; Sung-Kyoo Hwang
Journal:  J Korean Neurosurg Soc       Date:  2019-11-28

9.  Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.

Authors:  Daniel T T Chua; Shao-Xiong Wu; Victor Lee; Janice Tsang
Journal:  Head Neck Oncol       Date:  2009-05-23

10.  Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery.

Authors:  Daniel T T Chua; Kwan-Ngai Hung; Victor Lee; Sherry C Y Ng; Janice Tsang
Journal:  BMC Cancer       Date:  2009-04-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.